Delivery Order SPE2DB24D1107-SPE2DB25FZGS3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,893.18 to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3 mL syringes) with a completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.55 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 20, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,270.30 to AmerisourceBergen Drug Corp for Comirnaty 2024-25 vaccine (12 years and up, 0.3mL syringes) with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued on August 18, 2025, carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,175.75 on July 8, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3 mL syringes. This firm fixed-price delivery order, which was not set aside for small business, is scheduled for completion by July 9, 2025, with performance at the awardee's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3ml syringes, with a contract ceiling value of $2,220.84 and an ultimate completion date of March 13, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,270.30 on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, identified as COMIRNATY 2024-25 (12 years and up) at 0.3 milliliters, represents a single-dose vaccine supply for military healthcare operations. The contract was competitively awarded with no set-aside provisions and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $3,810.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine product (12 years and up, 0.3 mL syringes) with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract was issued on June 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $6,310.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12-year and older formulation, 0.3mL) with a completion date of October 16, 2025. This non-set-aside contract was competitively awarded on September 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,540.60 to AmerisourceBergen Drug Corp for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3 mL syringes. The award was made on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizing firm fixed price delivery order contract terms. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility and was awarded competitively without set-aside designation. This...
- The Defense Logistics Agency awarded a $12,621.20 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine product (12-year-old formulation, 0.3mL syringes) with an ultimate completion date of October 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed from the vendor's location...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGS3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3mL) on September 24, 2025, with a ceiling value of $1,262.12 and completion deadline of October 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical distributor supporting federal medical procurement needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. As a prime vendor under this IDC, AmerisourceBergen supplies vaccines, specialty medications, brand-name and generic drugs, and associated medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent performance on competitively awarded delivery orders demonstrates its capability to meet federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/24/25 |